Clinical Laserthermia Systems AB (publ) (CLS-B) — Net Asset Quality Index
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Net Asset Quality Index of 85.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr67.44 Million minus total liabilities of Skr9.92 Million yields net assets of Skr57.52 Million. A higher index indicates a stronger, lower-leverage balance sheet. See how many days can Clinical Laserthermia Systems AB (publ) fund operations to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Clinical Laserthermia Systems AB (publ) Net Asset Quality Index Over Time (2008–2025)
This chart shows how Clinical Laserthermia Systems AB (publ)'s Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the index stands at 85.3%, representing net assets of Skr57.52 Million against total assets of Skr67.44 Million SEK. Explore Clinical Laserthermia Systems AB (publ) (CLS-B) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Clinical Laserthermia Systems AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CLS-B company net worth.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.9% | Skr66.48 Million | Skr76.49 Million | Skr10.00 Million | ▲ +3.3 pp |
| 2024 | 83.6% | Skr65.69 Million | Skr78.56 Million | Skr12.88 Million | ▲ +8.2 pp |
| 2023 | 75.4% | Skr43.53 Million | Skr57.73 Million | Skr14.20 Million | ▲ +59.5 pp |
| 2022 | 15.9% | Skr7.87 Million | Skr49.51 Million | Skr41.64 Million | ▼ -15.9 pp |
| 2021 | 31.7% | Skr21.18 Million | Skr66.74 Million | Skr45.55 Million | ▲ +0.4 pp |
| 2020 | 31.4% | Skr13.93 Million | Skr44.40 Million | Skr30.47 Million | ▲ +13.3 pp |
| 2019 | 18.1% | Skr7.00 Million | Skr38.67 Million | Skr31.67 Million | ▼ -67.7 pp |
| 2018 | 85.8% | Skr49.81 Million | Skr58.02 Million | Skr8.21 Million | ▲ +12.4 pp |
| 2017 | 73.4% | Skr33.00 Million | Skr44.94 Million | Skr11.94 Million | ▲ +10.9 pp |
| 2016 | 62.5% | Skr17.06 Million | Skr27.30 Million | Skr10.24 Million | ▼ -24.9 pp |
| 2015 | 87.4% | Skr19.46 Million | Skr22.27 Million | Skr2.81 Million | ▲ +2.0 pp |
| 2014 | 85.4% | Skr31.58 Million | Skr36.95 Million | Skr5.38 Million | ▼ -3.9 pp |
| 2013 | 89.4% | Skr26.09 Million | Skr29.20 Million | Skr3.11 Million | ▲ +4.1 pp |
| 2012 | 85.2% | Skr17.09 Million | Skr20.06 Million | Skr2.97 Million | ▲ +1.9 pp |
| 2011 | 83.3% | Skr10.83 Million | Skr13.01 Million | Skr2.17 Million | ▼ -4.8 pp |
| 2010 | 88.1% | Skr10.36 Million | Skr11.76 Million | Skr1.41 Million | ▲ +7.2 pp |
| 2009 | 80.8% | Skr6.63 Million | Skr8.20 Million | Skr1.57 Million | ▲ +14.2 pp |
| 2008 | 66.6% | Skr3.68 Million | Skr5.52 Million | Skr1.85 Million | — |